Pasar al contenido principal

ESTUDIO DE LA CONTRIBUCION CELULAR NO AUTONOMA EN LA PATOGENESIS DE LA EP: MECANISMOS MOLECULARES IMPLICADOS Y POTENCIAL TERAPEUTICO

PID2022-139546OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model

  • Blasco-Agell, Lucas
  • Pons-Espinal, Meritxell
  • Testa, Veronica
  • Roch, Gerard|||0000-0002-9045-0579
  • Montero-Muñoz, Jara
  • Fernandez Carasa, Irene|||0000-0002-8195-3510
  • Baruffi, Valentina
  • González Sepúlveda, Marta|||0000-0002-5627-847X
  • Richaud-Patin, Yvonne
  • Jimenez, Senda
  • Cuadros, Thais|||0000-0001-6994-2424
  • Cladera-Sastre, Joana Margalida
  • Compte, Joan|||0000-0001-5447-5122
  • Manglano-Artuñedo, Zoe
  • Ventura, Salvador|||0000-0002-9652-6351
  • Juan, Manel|||0000-0002-3064-1648
  • Tolosa, Eduardo
  • Raya, Ángel|||0000-0003-2189-9775
  • Vila Bover, Miquel|||0000-0002-1352-989X
  • Consiglio, Antonella
Parkinson's disease (PD) is a progressive, incurable neurodegenerative disorder characterized by the loss of neuromelanin (NM)-containing dopamine neurons (DAn) in the substantia nigra of the midbrain. Non-neuronal cells are increasingly recognized as contributors to PD. We generated human microglia-like cells (hMG) from induced pluripotent stem cells (iPSC) derived from patients with LRRK2 PD-causing mutations, gene-corrected isogenic controls, and healthy donors. While neither genotype induced neurodegeneration in healthy DAn, LRRK2 hMG become hyperreactive to LPS stimulation, exhibiting increased cytokine expression, reactive oxygen species, and phagocytosis. When exposed to NM-containing particles, but not α-synuclein fibrils, LRRK2 hMG trigger DAn degeneration, in a process that is prevented by pre-treatment with the immunomodulatory drug ivermectin. Finally, post-mortem analysis of midbrain tissue of LRRK2-PD patients show increased microglia activation around NM-containing neurons, confirming our in vitro findings. Overall, our work highlights NM-activated microglia's role in PD progression, and provides a model for testing therapeutic targets. (Figure presented.).